HANSEN JOHN DAVID

CIK 00011861232 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001186123

Recent Transactions

44 trades

Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2018-04-02−13,561→ 0 total
Tax Payment
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-04-02−4,689→ 190,827 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-04-02+13,561→ 195,516 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2018-02-21+290,000→ 290,000 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-01-16$0.92/sh−59,263→ 536,730 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-01-12$0.96/sh−18,582→ 595,993 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-01-11$0.98/sh−64,015→ 614,575 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-01-10$0.96/sh−110,093→ 678,590 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2018-01-08+727,210→ 788,683 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2018-01-08−727,210→ 0 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2017-10-02+551,156→ 551,156 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2017-09-15+176,054→ 176,054 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2017-05-19$2.00/sh+500,000→ 500,000 total
Purchase
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2017-05-19$1.75/sh+4,286→ 65,759 total
Purchase
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2017-05-19+4,842→ 70,601 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Class A Warrant
2017-05-19−3,119→ 0 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Class B Warrant
2017-05-19−3,119→ 0 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2017-04-12$2.00/sh−10,216→ 61,473 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2017-04-11$2.00/sh−250→ 71,689 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2017-04-10$2.00/sh−560→ 71,939 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2017-04-07$2.00/sh−666→ 72,499 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2017-04-06$2.15/sh−1,501→ 73,165 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2017-04-05$2.15/sh−2,450→ 74,666 total
Sale
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2017-04-04$2.25/sh−1,100→ 77,116 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2017-04-02+40,687→ 78,216 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2017-04-02−40,687→ 40,687 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2017-02-06$2.99/sh+250,000→ 250,000 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2017-01-01$3.38/sh+63,400→ 63,400 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2016-08-29$5.00/sh+63,400→ 63,400 total
Purchase
MABVAX THERAPEUTICS HOLDINGS, INC.
Class A Warrant
2016-08-17+3,119→ 3,119 total
Purchase
MABVAX THERAPEUTICS HOLDINGS, INC.
Class B Warrant
2016-08-17+3,119→ 3,119 total
Purchase
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2016-08-17+3,119→ 37,529 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2016-04-04−301,184→ 602,166 total
Exercise/Conversion
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2016-04-04+301,084→ 367,782 total
Tax Payment
MABVAX THERAPEUTICS HOLDINGS, INC.
Common Stock
2016-04-04−113,148→ 254,634 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Purchase Common Stock
2016-02-16$0.49/sh+500,000→ 500,000 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Restricted Stock Unit
2015-04-02+903,250→ 903,250 total
Award
MABVAX THERAPEUTICS HOLDINGS, INC.
Option to Buy Common Stock
2015-04-02$2.30/sh+903,250→ 903,250 total
Sale
AVANIR PHARMACEUTICALS, INC.
Class A Common Stock
2005-01-03$3.40/sh−10,200→ 15,000 total
Sale
AVANIR PHARMACEUTICALS, INC.
Class A Common Stock
2005-01-03$3.42/sh−600→ 15,000 total
Sale
AVANIR PHARMACEUTICALS, INC.
Class A Common Stock
2005-01-03$3.41/sh−14,400→ 15,600 total
Sale
AVANIR PHARMACEUTICALS, INC.
Class A Common Stock
2005-01-03$3.39/sh−4,800→ 25,200 total
Sale
AVANIR PHARMACEUTICALS, INC.
Class A Common Stock
2004-09-13$3.15/sh−15,000→ 30,000 total
Award
AVANIR PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
2004-04-06+10,000→ 10,000 total

Companies

Recent Filings

Address

11588 SORRENTO VALLEY ROAD, SUITE 20

SAN DIEGO, CA, 92121

View on SEC.gov